No. 1: a clear picture from supplier to factory — and all the milestones in between.

Dennis McRae, senior director of consumer and industrial products with West Monroe, explains why it has become "very feasible" for manufacturers to shift operations from China and other parts of Asia back to the U.S.

Claudia Lewis, partner with Venable LLP, describes how the U.S. Food and Drug Administration is revising its policies, practices and regulations in response to the coronavirus pandemic.

The U.S.-Mexico-Canada Agreement (USMCA) promises to be a bright light for many businesses struggling to find their path to recovery.

Elements of the agriculture and food industries that have been slow to adopt technology are feeling the most pain from the coronavirus pandemic.

Ray Huang, head of Asia and principal engineer with Exponent, provides an update on the progress of factories in Asia and elsewhere in resuming full operations — and discusses the obstacles that might stand in the way.

U.S. Customs and Border Protection recently reported the seizure of a shipment of Pokémon action figurines valued at more than $600,000.

Robert Sanders, associate professor and chair of national security at the University of New Haven's Henry C. Lee College of Criminal Justice & Forensic Sciences, reviews the legal implications of lawsuits against China for botching that country's response in the early days of the coronavirus pandemic.

Colin Barnacle, partner with Akerman LLP, provides details of the firm's Return to Work Resource Guide.

Christopher Tang, professor at UCLA's Anderson School of Management, describes what it will take for hospital and healthcare supply chains to recover from the COVID-19 pandemic.